Ignite Creation Date:
2025-12-24 @ 12:22 PM
Ignite Modification Date:
2026-02-02 @ 4:53 PM
Study NCT ID:
NCT00863161
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2009-03-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Renal Impairment Study
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9120C00022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Debra G. Silberg, MD, PhD, Medical Science Director, AZD3355
Old Organization:
AstraZeneca Pharmaceuticals